Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

Wed, 05th Dec 2018 08:44

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US Treasury yields dropped below zero.

Traders were sceptical around the Trump-Xi agreement announced over the weekend.

In China, traders paid little attention to encouraging services data. The benchmark Shanghai Composite index fell 16.15 points or 0.6% to 2,649.81 while Hong Kong's Hang Seng index tumbled 1.6% to close at 26,819.68.

The services sector in China continued to expand in November, and at an accelerated rate, the latest survey from Caixin revealed with a PMI score of 53.8. That beat expectations for 50.8, which would have been unchanged from the October reading.

Japanese shares fell after a plunge on Wall Street overnight on growth and trade concerns. The Nikkei average shed 116.72 points or 0.5% to finish at 21,919.33, while the broader Topix index closed 0.5% lower at 1,640.49.

China-focused shares ended lower, with Fanuc losing 3.4% and Rohm declining 1.5%. In the tech sector, Advantest slumped 4.6% and Tokyo Electron shed 1.8%.

Drug giant Takeda rose 1.1% after it received shareholder approval to acquire Irish pharmaceuticals firm Shire in a deal worth around USD60 billion.

On the economic front, the latest survey from Nikkei showed that the services sector in Japan continued to expand in November, albeit at a fractionally slower pace with a PMI score of 52.3, down from 52.4 in October.

Australian markets hit a two-week low before ending off their day's lows, dragged down by banks after official data showed the economy slowed more than expected in the third quarter of 2018.

Australia's GDP grew a seasonally adjusted 0.3% sequentially in the last quarter, missing expectations for an increase of 0.6% and down from 0.9% in the second quarter. On a yearly basis, GDP expanded 2.8% - again missing forecasts for 3.3% and down from 3.4% in the three months prior.

Another report from the Australian Industry Group revealed that the service sector in Australia continued to expand in November, and at a sharply faster rate.

The benchmark S&P/ASX 200 index ended down 44.70 points or 0.8% at 5,668.40 after losing 1.0% in the previous session. The broader All Ordinaries index dropped 48.40 points or 0.8% to 5,749.10

The big four banks fell between 0.7% and 1.2%. Mining heavyweights BHP Billiton and Rio Tinto rose modestly while energy majors Oil Search, Origin Energy, Beach Energy and Santos lost around 2% as oil resumed declines in Asian trade.

Rare earths miner Lynas Corp plummeted 22% after tough new conditions were announced for the company's license to operate in Malaysia.

Seoul stocks recovered some lost ground after hitting over one-week low earlier in the day. The benchmark Kospi fell over 1% before recouping some loss to end the session down 13.04 points or 0.6% at 2,101.31 on continued uncertainty over the Sino-US trade war.

New Zealand shares fell sharply as a flattening Treasury yield curve and doubts about the durability of the US-China trade war truce sparked worries about global growth.

The benchmark S&P/NZX 50 index dropped 84.23 points or 1.0% to finish at 8,781.53. Trade Me shares bucked the weak trend to end 3.1% higher after a second bidder emerged for the e-commerce leader.

Singapore's Straits Times index was down 0.6%. The country's private sector continued to expand in November, and at a faster rate, the latest survey from Nikkei showed with a PMI score of 53.8, up from 52.6 in October.

Overnight, US stocks tanked as the initial euphoria generated by a truce between the US and China over trade evaporated and an inverted yield curve in bond markets signalled an economic slowdown.

The Dow Jones Industrial Average tumbled 3.1%, the tech-heavy Nasdaq Composite plummeted 3.8% and the S&P 500 lost 3.2%.

More News
4 Jan 2019 12:09

LONDON MARKET MIDDAY: Miners Keep FTSE Higher Ahead Of US Payrolls

LONDON (Alliance News) - Stocks in London remained higher midday Friday buoyed by miners, confirmed US-China trade talks and positive Chinese economic data.The FTSE 100 index was up 92.54 points,

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
5 Dec 2018 17:12

LONDON MARKET CLOSE: Stocks End Lower Amid Global Growth Fears

LONDON (Alliance News) - Stocks in London ended lower on Wednesday as concerns over global growth and trade wars continued to plague investors. The FTSE 100 index closed down 100.92 points, or at

Read more
5 Dec 2018 13:58

UPDATE: Takeda, Shire Secure Deal Approval From Shareholders

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 12:12

LONDON MARKET MIDDAY: Risk-Off Mood As Weak UK Services Adds To Worry

LONDON (Alliance News) - London stocks slid on Wednesday as risk-off sentiment replaced the more upbeat mood at start of the week, with markets in the US and Asia slumping overnight amid global of

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 08:40

LONDON MARKET OPEN: Stocks Sink Amid Trade War, US Economy Jitters

LONDON (Alliance News) - With Monday's gains a distant memory, the FTSE 100 shed nearly 100 points at the London open Wednesday amid renewed global trade fears and worries over the strength of

Read more
5 Dec 2018 08:00

Takeda shareholders approve £46bn Shire takeover

(Sharecast News) - Takeda Pharmaceutical shareholders have approved its £46bn takeover of London-listed pharmaceutical group Shire.

Read more
5 Dec 2018 06:58

LONDON MARKET EARLY CALL: FTSE 100 Seen Down 60 Points After NY Fall

LONDON (Alliance News) - Stocks in London are set to open sharply lower on Wednesday following a slump in New York overnight that was tracked by Asian markets, with the optimism seen at the start

Read more
5 Dec 2018 06:43

TOP NEWS: Takeda Shareholders Approve Acquisition Of Shire

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 04:06

UPDATE 1-Takeda shareholders give nod for $59 bln Shire acquisition

* Deal is the biggest overseas acquisition by Japanese firm * Some had opposed massive debt required for deal * CEO Weber has promised to slash costs (Adds details about Takashi Dec

Read more
5 Dec 2018 03:32

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a but

Read more
2 Dec 2018 11:57

Sunday newspaper round-up: US-China, Brexit, Royal Mail, Barclays, Shire

(Sharecast News) - China and the United States have agreed to halt additional tariffs as both nations engage in new trade negotiations with the goal of reaching an agreement within 90 days, the White House said on Saturday after talks between President Donald Trump and President Xi Jinping in Argentina. - Sunday Telegraph

Read more
30 Nov 2018 08:35

Shire Wins European Okay For Takhzyro Drug Ahead Of January Delisting

LONDON (Alliance News) - Shire PLC said Friday its Takhzyro injection has been approved in Europe to treat hereditary angioedema.Takhzyro is a preventative treatment for hereditary a that a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.